Log In
Print this Print this

PF-4360365 (formerly RN1219)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionHumanized anti-amyloid mAb targeting the C-terminal end of the beta amyloid 1-40 peptide
Molecular Target Beta amyloid
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today